Cargando…
Ultrasound and Transcriptomics Identify a Differential Impact of Cisplatin and Histone Deacetylation on Tumor Structure and Microenvironment in a Patient-Derived In Vivo Model of Gastric Cancer
The reasons behind the poor efficacy of transition metal-based chemotherapies (e.g., cisplatin) or targeted therapies (e.g., histone deacetylase inhibitors, HDACi) on gastric cancer (GC) remain elusive and recent studies suggested that the tumor microenvironment could contribute to the resistance. H...
Autores principales: | Venkatasamy, Aina, Guerin, Eric, Blanchet, Anais, Orvain, Christophe, Devignot, Véronique, Jung, Matthieu, Jung, Alain C., Chenard, Marie-Pierre, Romain, Benoit, Gaiddon, Christian, Mellitzer, Georg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467189/ https://www.ncbi.nlm.nih.gov/pubmed/34575561 http://dx.doi.org/10.3390/pharmaceutics13091485 |
Ejemplares similares
-
HDAC4 Levels Control Sensibility toward Cisplatin in Gastric Cancer via the p53-p73/BIK Pathway
por: Spaety, Marie-Elodie, et al.
Publicado: (2019) -
Morpho-functional analysis of patient-derived xenografts reveals differential impact of gastric cancer and chemotherapy on the tumor ecosystem, affecting immune check point, metabolism, and sarcopenia
por: Venkatasamy, A., et al.
Publicado: (2022) -
Bypassing the Resistance Mechanisms of the Tumor Ecosystem by Targeting the Endoplasmic Reticulum Stress Pathway Using Ruthenium- and Osmium-Based Organometallic Compounds: An Exciting Long-Term Collaboration with Dr. Michel Pfeffer
por: Gaiddon, Christian, et al.
Publicado: (2021) -
The EXTREME Regimen Associating Cetuximab and Cisplatin Favors Head and Neck Cancer Cell Death and Immunogenicity with the Induction of an Anti-Cancer Immune Response
por: De Azevedo, Justine, et al.
Publicado: (2022) -
Histone Deacetylase Functions in Gastric Cancer: Therapeutic Target?
por: Badie, Amandine, et al.
Publicado: (2022)